PK/PD Levobupivacaine with and Without Epinephrine After Ultrasound Guided ESP Block

PHASE4CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

April 3, 2019

Primary Completion Date

August 1, 2021

Study Completion Date

March 9, 2022

Conditions
Anesthetics ComplicationsAnesthetic ToxicityBupivacaine OverdoseNerve BlockSurgery
Interventions
DRUG

Levobupivacaine 0.25% with epinephrine 5 ug/ml

"The block will be performed under ultrasound vision at T5 level, with the patient seated.~Once the ultrasound image is achieved, a 100 mm, 20 G Stimuplex needle will be punctured and a solution of levobupivacaine 0.25% with epinephrine 5 ug / ml until completing a volume of 20 ml in fractional form."

DRUG

Levobupivacaine 0.25% without epinephrine 5 ug/ml

"The block will be performed under ultrasound vision at T5 level, with the patient seated.~Once the ultrasound image is achieved, a 100 mm, 20 G Stimuplex needle will be punctured and a solution of levobupivacaine 0.25% without epinephrine 5 ug / ml until completing a volume of 20 ml in fractional form."

Trial Locations (1)

450881

Pontificia Universidad Catolica de Chile, Santiago

All Listed Sponsors
lead

Pontificia Universidad Catolica de Chile

OTHER

NCT04799184 - PK/PD Levobupivacaine with and Without Epinephrine After Ultrasound Guided ESP Block | Biotech Hunter | Biotech Hunter